SUB creates value by owning a portfolio of approved Chinese herbal medicine and by commercialization in EU.

Achievements: SU BioMedicine has realized, as the first company in the world, the registration of a Chinese medicinal product according to tHMP (traditional Herbal medicinal product) rules (directive 2004/24/EC) in Europe that is produced in China. A press conference was given on April 18, 2012 and organized by the Chinese government minister of Health Chen Zhu, the vice president of the National People’s congress San Guo Wei and the Chinese Academy of Sciences in the prestigious People’s Hall in Beijing. Present were 400 people from the press including CCTV.

Products portfolio: Chinese herbal medicine in treatment/ prevention of diseases in the area of pain, woman’s health, cold etc.